Myeloid-derived suppressor cells play a role in glioblastoma, Cleveland Clinic researchers have shown. These researchers now plan a clinical trial aimed at reducing blood levels of these immunosuppressive cells.
The Cleveland Multiport Catheter: A New Take on Convection-Enhanced Delivery to the CNS
This novel CED device promises larger volume of drug distribution than with prior CED devices. Early human testing in glioma patients supports that hope, and use in other CNS conditions is being explored.